The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Drug-Related Deaths in a Department of Internal Medicine
Abstract
BACKGROUND: Drug therapy is associated with adverse effects, and fatal adverse drug events (ADEs) have become major hospital problems. Our study assesses the incidence of fatal ADEs in a major medical department and identifies possible patient characteristics signifying fatal ADE risk. METHODS: During a 2-year period, a multidisciplinary study group examined all 732 patients who died--5.2% of the 13992 patients admitted to the Department of Internal Medicine, Central Hospital of Akershus, Nordbyhagen, Norway. Decisions about the presence or absence of fatal ADEs were based on aggregated clinical records, autopsy results, and findings from premortem and postmortem drug analyses. RESULTS: In 18.2% of the patients (133/732) (95% confidence interval, 15.4%-21.0%), deaths were classified as being directly (64 [48.1%] of 133) or indirectly (69 [51.9%] of 133) associated with 1 or more drugs (this equals 9.5 deaths per 1000 hospitalized patients). Those with fatal ADEs (cases) were older, had more diseases, and used more drugs than those without fatal ADEs (noncases). In 75 of the 133 patients with fatal ADEs, autopsy findings and/or drug analysis data were decisive for recognizing the ADEs; in 62 of the remaining 595 patients, similar data proved necessary to exclude the suspicion of a fatal ADE. Major culprit drugs were cardiovascular, antithrombotic, and sympathomimetic agents. CONCLUSIONS: Fatal ADEs represent a major hospital problem, especially in elderly patients with multiple diseases. A higher number of drugs administered was associated with a higher frequency of fatal ADEs, but whether a high number of drugs is an independent risk factor for fatal ADEs is unsettled. Autopsy results and the findings of premortem and postmortem drug analyses were important for recognizing and excluding suspected fatal ADEs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
To Err Is Human: Building a Safer Health System
(2000) · National Academies Press eBooks · doi:10.17226/9728 · Cited by 14,044
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Leape, L. L., Brennan, T. A., Laird, N., Lawthers, A. G., Localio, A. R., Barnes, B. A., Hebert, L., Newhouse, J. P., Weiler, P. C., & Hiatt, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240605 · Cited by 3,711
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Bates, D. W. (1997) · JAMA · doi:10.1001/jama.277.4.307 · Cited by 1,674
Systems Analysis of Adverse Drug Events
Leape, L. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530010049034 · Cited by 1,404
Relationship between medication errors and adverse drug events
Bates, D. W., Boyle, D. L., Vliet, M. B. V., Schneider, J., & Leape, L. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02600255 · Cited by 981
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-Analysis of Prospective Studies
LAZAROU, J., POMERANZ, B. H., & COREY, P. N. (1999) · Survey of Anesthesiology · doi:10.1097/00132586-199902000-00059 · Cited by 670
Cullen, D. J., Sweitzer, B. J., Bates, D. W., Burdick, E., Edmondson, A., & Leape, L. L. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00014 · Cited by 611
Thomas, E. J. (2000) · BMJ · doi:10.1136/bmj.320.7237.741 · Cited by 423
Raschke, R. A., Gollihare, B., Wunderlich, T. A., Guidry, J. R., Leibowitz, A. I., Peirce, J. C., Lemelson, L., Heisler, M. A., & Susong, C. (1998) · JAMA · doi:10.1001/jama.280.15.1317 · Cited by 357
Kramer, M. S. (1979) · JAMA · doi:10.1001/jama.1979.03300070019017 · Cited by 346
Patient Risk Factors for Adverse Drug Events in Hospitalized Patients
Bates, D. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.21.2553 · Cited by 330
Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population
Goldberg, R. M., Mabee, J., Chan, L., & Wong, S. (1996) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(96)90147-3 · Cited by 319
Rational Diagnosis and Treatment
Wulff, H. R. (1986) · Journal of Medicine and Philosophy · doi:10.1093/jmp/11.2.123 · Cited by 245
The Epidemiology of Serious Adverse Drug Reactions Among the Elderly
Atkin, P. A., Veitch, P. C., Veitch, E. M., & Ogle, S. J. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00005 · Cited by 203
Counting the Costs of Drug-Related Adverse Events
White, T. J., Arakelian, A., & Rho, J. P. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915050-00003 · Cited by 197
The ambiguity of adverse drug reactions
Koch‐Weser, J., Sellers, E. M., & Zacest, R. (1977) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562895 · Cited by 132
Drugs and Adverse Drug Reactions: How Worried Should We Be?
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.279.15.1216 · Cited by 104
Predicting Mortality and Length of Stay of Geriatric Patients in an Acute Care General Hospital
Incalzi, R. A., Gemma, A., Capparella, O., Terranova, L., Porcedda, P., Tresalti, E., & Carbonin, P. (1992) · Journal of Gerontology · doi:10.1093/geronj/47.2.m35 · Cited by 89
Computerized surveillance of adverse drug reactions in hospital: Implementation
Lévy, M., Azaz‐Livshits, T., Sadan, B., Shalit, M., Geißlinger, G., & Brune, K. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050571 · Cited by 82
Tegeder, I., Levy, Muth‐Selbach, Oelkers, Neumann, Dormann, Azaz‐Livshits, Criegee‐Rieck, Schneider, Hahn, et al. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00926.x · Cited by 64
Ways to minimize adverse drug reactions
Cohen, J. S. (1999) · Postgraduate Medicine · doi:10.3810/pgm.1999.09.688 · Cited by 59
Brawn, L. A., & Castleden, C. M. (1990) · Drug Safety · doi:10.2165/00002018-199005060-00003 · Cited by 40
Characteristics Associated with Ability to Prevent Adverse Drug Reactions in Hospitalized Patients
Seeger, J. D., Kong, S. X., & Schumock, G. T. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03149.x · Cited by 40
Drug-Associated Deaths of Medical Inpatients
Caranasos, G. J. (1976) · Archives of Internal Medicine · doi:10.1001/archinte.1976.03630080014006 · Cited by 36
Otero, M. J., Domínguez‐Gil, A., Bajo, Á. B., & MADERUELO, J. A. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.15.1185.30581 · Cited by 7
Cited by
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Braunstein, J. B., Anderson, G. F., Gerstenblith, G., Weller, W., Niefeld, M., Herbert, R., & Wu, A. W. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00947-1 · Cited by 779
Aging Biology and Geriatric Clinical Pharmacology
McLean, A. J., & Le Couteur, D. G. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.4 · Cited by 771
Polypharmacy and Prescribing Quality in Older People
Steinman, M. A., Seth Landefeld, C., Rosenthal, G. E., Berthenthal, D., Sen, S., & Kaboli, P. J. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00889.x · Cited by 537
Clinical, educational, and epidemiological value of autopsy
Burton, J. L., & Underwood, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60376-6 · Cited by 440
Metadata
- Authors
- Ebbesen, J., Buajordet, I., Erikssen, J., Brørs, O., Hilberg, T., Svaar, H., & Sandvik, L.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2001-10-22
- Volume
- 161
- Issue
- 19
- Pages
- 2317
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1968030991
- Cited by
- 254
- References
- 27
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.